The average one-year price target for Belite Bio, Inc - Depositary Receipt (NasdaqCM:BLTE) has been revised to $215.73 / share. This is an increase of 11.24% from the prior estimate of $193.93 dated ...

Nuvation Bio Inc. (NYSE:NUVB) is one of the 12 Best Stocks to Buy According to Billionaire David Abrams. Nuvation Bio Inc.

Upsized the debt facility and raised equity capital in late 2025 to ensure financial flexibility during the commercial ...

Appointment of Stacy Price as Chief Technology Officer strengthens Upstream Bio's leadership team with her extensive experience in technical operations and product development in the biotechnology ...

INmune Bio Inc. (NASDAQ:INMB) stock surged by 24.72% in after-hours trading on Friday. The company announced a novel selective soluble TNF inhibitor, which is likely to have influenced the stock’s ...

Climb Bio appointed Dr. Perrin Wilson as Chief Business Officer to strengthen its leadership in developing immune-mediated disease treatments. Climb Bio, Inc. has announced the appointment of Dr.